Trials / Withdrawn
WithdrawnNCT01731028
Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®
Non-interventional, Observational Study of the Application of Zomacton® in the Treatment of Growth Hormone Deficiency in Routine Clinical Practice
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 3 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner's syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatropin | Somatropin powder and solvent for solution for injection |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2017-12-01
- Completion
- 2018-06-01
- First posted
- 2012-11-21
- Last updated
- 2013-02-01
Source: ClinicalTrials.gov record NCT01731028. Inclusion in this directory is not an endorsement.